MGC's OXYCAPT™ received Packaging Innovation Award at Pharmapack 2025
January 24, 2025
Mitsubishi Gas Chemical Company, Inc. (MGC; Head Office: Chiyoda-ku, Tokyo; President: Masashi Fujii) proudly announces MGC's OXYCAPT™ received Packaging Innovation Award at Pharmapack 2025 in Paris held by Informa Markets.
OXYCAPT™ is a three-layered plastic container having both properties of glass and plastic. Cyclo olefin polymer (COP), the most reliable polymer in the pharma industry, is used for the inner and outer layer and a new polymer with high gas barrier properties developed by MGC is used for the middle layer. The product has achieved excellent O2 & CO2 barrier, excellent ultraviolet barrier, very low extractables, very low protein adsorption, excellent break resistance at cryogenic temperature, etc. The O2 & CO2 barrier is about 20 times better than the COP monolayer container. OXYCAPT™ also has excellent ultraviolet barrier even though it is transparent. These excellent properties contribute to the stability of drugs sensitive to O2, CO2 and UV.
Especially, as the new modality such as cell & gene therapy products has been developed recently and resistance to deep-freezing and transportation with dry ice are required, conventional glass and plastic containers cannot be used in many cases. OXYCAPT™ demonstrates its excellent properties even at these harsh conditions and contributes to achieving long-term stability of cell & gene therapy products.
To contribute to spread of the latest modality, MGC will carry out further research & development and create unique products.
END
Inquiries
Public Relations Department
Administrative & Personnel Division
MITSUBISHI GAS CHEMICAL COMPANY, INC.
TEL: +81-3-3283-5040